Ohr Pharmaceutical, Inc.

Ohr Pharmaceutical, Inc.

Sector: Pharmaceutical Preparations Region: NY, United States

: | Nasdaq: OHRP

Similar to: Guerbet SA, Hutchison China MediTech Ltd., Cephalon, Inc.

Ohr Pharmaceutical, Inc. operates as a biotechnology company, which is focused on the development of its acquired compounds. Its products include OHR/AVR 118 for the treatment of Cancer Cachexia and EVIZON, which are used for the treatment of the wet form of age related macular degeneration. The company was founded in 2008 and is headquartered in New York, NY.

News & Analysis

You may also be interested in: